BeStock  
Stocks › Biotechnology › NKTR

Nektar Therapeutics NKTR

US equityMarket cap rank #3135Biotechnology
$30.20 −$2.34 (-7.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.20 0.00%
Open$31.66
Prev close$32.54
Day range$30.13 – $32.35
Volume1.02M
Market cap$1.03B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$9.39M-20.4% YoY
Operating profit-$59.31M-88.1% YoY
Net profit-$55.65M-56.7% YoY
Diluted EPS-$1.63+12.8% YoY
Free cash flow-$72.33M-48.0% YoY
Operating cash flow-$71.93M

Revenue, last 8 quarters

$29.2MDec '24$10.5MMar '25$11.2MJun '25$11.8MSep '25$21.8MDec '25$10.9MMar '26$10.1MJun '26$9.4MSep '26

Net profit, last 8 quarters

$7.3MDec '24$-50.9MMar '25$-41.6MJun '25$-35.5MSep '25$-36.1MDec '25$-44.9MMar '26$-40.6MJun '26$-55.7MSep '26

Diluted EPS by quarter

0.45Dec '24-3.62Mar '25-2.95Jun '25-1.87Sep '25-1.78Dec '25-1.82Mar '26-1.23Jun '26-1.63Sep '26

Free cash flow by quarter

$-46.6MDec '24$-49.1MMar '25$-45.8MJun '25$-48.9MSep '25$-65.0MDec '25$-44.3MMar '26$-75.9MJun '26$-72.3MSep '26

Annual revenue

$152.9MFY20$101.9MFY21$92.1MFY22$90.1MFY23$98.4MFY24$55.2MFY25

Profitability & balance sheet

Operating margin-303.6%
Net margin-339.7%
Return on equity-37.9%
Return on assets-26.5%
Return on invested capital-31.6%
Current ratio9.00
Liabilities / assets18.1%
Cash & investments$614.36M
Total debt$51.00M
Net cash (debt)$563.36M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $9.39M $10.13M $10.86M $55.23M $21.81M
Total Operating Revenue $9.39M $10.13M $10.86M $55.23M $21.81M
Operating Expense $68.69M $51.89M $49.12M $186.00M $40.90M
Selling and Admin Expenses $24.57M $12.77M $13.44M $68.67M $11.19M
-General & Admin Expense $24.57M $12.77M $13.44M $68.67M $11.19M
Research & Development $44.12M $39.13M $35.68M $117.33M $29.71M
Operating Profit -$59.31M -$41.76M -$38.26M -$130.77M -$19.09M
Net Non-Operating Interest Income (Expense) $2.82M $2.14M -$3.70M -$15.75M -$6.99M
Non-Operating Interest Income $9.58M $9.35M $4.24M $10.44M $2.78M
Non-Operating Interest Expense $6.76M $7.21M $7.94M $26.18M $9.77M
Other Income (Expense) $1.45M -$678,000.00 -$1.13M -$8.97M -$8.62M
Special Income (Charges) $1.50M -$578,000.00 -$796,000.00 -$9.33M -$8.58M
-Less:Restructuring and Mergern & Acquisition -$1.50M $578,000.00 $796,000.00 $4.89M $4.13M
Other Non-Operating Income (Expenses) -$59,000.00 -$100,000.00 -$336,000.00 $361,000.00 -$44,000.00
Pretax Profit -$55.05M -$40.30M -$43.09M -$155.49M -$34.70M
Tax $22,000.00 $2,000.00 $64,000.00 -$138,000.00 $31,000.00
$583,000.00 $319,000.00 $1.75M $8.73M $1.35M
Net Profit -$55.65M -$40.62M -$44.90M -$164.08M -$36.08M
Profit from Continuing Operations -$55.65M -$40.62M -$44.90M -$164.08M -$36.08M
Net Income to Parent Company -$55.65M -$40.62M -$44.90M -$164.08M -$36.08M
Net Income to Common Stockholders -$55.65M -$40.62M -$44.90M -$164.08M -$36.08M
Basic EPS -$1.63 -$1.23 -$1.82 -$9.73 -$1.78
Diluted EPS -$1.63 -$1.23 -$1.82 -$9.73 -$1.78
Cost of Revenue – – – $0.00 $0.00
Gross Profit – – – $55.23M $21.81M
-Less:Impairment of Capital Assets – – – $4.44M $4.44M
-Gain on Sale Of Business – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.04B $1.10B $763.27M $280.41M $280.41M
Total Current Assets $679.33M $739.40M $589.04M $266.27M $266.27M
Cash and Cash Equivalents & Short-Term Investments $614.36M $684.34M $568.60M $245.75M $245.75M
-Cash and Cash Equivalents $34.69M $39.27M $149.58M $15.12M $15.12M
-Short Term Investments $579.67M $645.07M $419.03M $230.64M $230.64M
Receivables $9.01M $4.76M $3.60M $1.78M $1.78M
-Accrued Interest Receivable $6.13M – – – –
-Other Receivables $2.88M $4.76M $3.60M $1.78M $1.78M
Prepaid Assets $55.97M $50.31M $16.84M $18.74M $18.74M
Total Non-Current Assets $357.92M $355.73M $174.23M $14.14M $14.14M
Net PPE $4.34M $4.26M – $5.00M $5.00M
-Gross PPE $4.34M $4.26M – $5.00M $5.00M
Investments and Advances $339.34M $340.48M $162.99M $3.49M $3.49M
-Long Term Equity Investment $839,000.00 $1.42M – $3.49M $3.49M
Non-Current Prepaid Assets $11.69M $8.67M – – –
Other Non-Current Assets $2.55M $2.32M $11.24M $5.65M $5.65M
Total Liabilities $187.53M $192.01M $187.06M $190.57M $190.57M
Total Current Liabilities $75.48M $70.99M $57.71M $53.54M $53.54M
Payables $18.13M $24.89M $10.03M $10.77M $10.77M
-Accounts Payable $18.13M $24.89M $10.03M $10.77M $10.77M
Current Accrued Expenses $24.43M $16.36M $20.14M $19.33M $19.33M
Short-Term Debt and Capital Lease Obligation $22.88M $22.71M $22.53M $20.50M $20.50M
-Current Capital Lease Obligation $22.88M $22.71M $22.53M $20.50M $20.50M
Total Non-Current Liabilities $112.05M $121.02M $129.35M $137.04M $137.04M
Long Term Debt and Capital Lease Obligation $51.00M $55.85M $60.63M $65.26M $65.26M
-Long Term Capital Lease Obligation $51.00M $55.85M $60.63M $65.26M $65.26M
Other Non-Current Liabilities $61.05M $65.17M $68.72M $71.78M $71.78M
Total Equity $849.72M $903.12M $576.22M $89.83M $89.83M
Stockholders' Equity $849.72M $903.12M $576.22M $89.83M $89.83M
Capital Stock $3,000.00 $3,000.00 $3,000.00 $2,000.00 $2,000.00
-Common Stock $3,000.00 $3,000.00 $3,000.00 $2,000.00 $2,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $4.76B $4.75B $4.38B $3.85B $3.85B
Retained Earnings -$3.90B -$3.85B -$3.81B -$3.76B -$3.76B
Less: Treasury Stock $0.00 $0.00 – $0.00 $0.00
Gains/Losses Not Affecting Retained Earnings -$3.95M -$1.76M -$1.03M $17,000.00 $17,000.00
-Available for Sale Securities – – $162.99M – –

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$71.93M -$75.77M -$44.30M -$208.51M -$64.96M
Net cash flow from continuing operations -$71.93M -$75.77M -$44.30M -$208.51M -$64.96M
Net Income from Continuing Operations -$55.65M -$40.62M -$44.90M -$164.08M -$36.08M
Gain/Loss from Continuing Operations $583,000.00 $319,000.00 $1.75M $8.73M $1.35M
Depreciation & Depletion & Amortization $169,000.00 $156,000.00 $151,000.00 $1.03M $190,000.00
Other Non-Cash Items -$2.62M -$1.26M -$4.58M -$28.75M -$12.04M
Change in Working Capital -$14.63M -$32.49M -$68,000.00 -$37.02M -$23.12M
-Change in Payables and Accrued Expense $3.04M $12.77M $1.39M -$6.41M -$7.52M
-Change in Other Current Assets -$13.17M -$40.83M $949,000.00 -$15.45M -$9.86M
-Change In Other Working Capital -$4.50M -$4.43M -$2.41M -$15.16M -$5.75M
Net cash flow from investing $66.90M -$399.11M -$350.79M -$1.20M $372,000.00
Net Cash Flow from Continuing Investing Activities $66.90M -$399.11M -$350.79M -$1.20M $372,000.00
Net PPE Purchase and Sale -$398,000.00 -$94,000.00 -$18,000.00 -$171,000.00 -$18,000.00
Net Investment Purchase and Sale $67.30M -$399.02M -$350.77M -$329,000.00 $390,000.00
Financing Cash Flow $448,000.00 $364.57M $529.55M $180.57M $38.67M
Net Cash Flow from Continuing Financing Activities $448,000.00 $364.57M $529.55M $180.57M $38.67M
Net Common Stock Issuance $0.00 $364.91M $525.52M $180.85M $38.26M
Proceeds from Stock Option Exercised $698,000.00 $878,000.00 $4.06M $866,000.00 $410,000.00
Net Other Financing Charges -$250,000.00 -$1.21M -$25,000.00 -$1.15M $0.00
Ending Cash Balance $34.69M $39.27M $149.58M $15.12M $15.12M
Net Change in Cash -$4.58M -$110.31M $134.46M -$29.14M -$25.92M
Beginning Cash Balance $39.27M $149.58M $15.12M $44.25M $41.03M
Effect of Exchange Rate Changes $0.00 $0.00 $0.00 $6,000.00 $0.00
Free Cash Flow -$72.33M -$75.86M -$44.32M -$208.68M -$64.98M
-Change in Receivables – – – $0.00 $0.00
-Change in Inventory – – – $0.00 $0.00
Net Business Purchase and Sale – – – -$697,000.00 –

Discussion

No comments yet — be the first to weigh in on NKTR.

Sign in to join the discussion.

Scroll to Top